ATLANYS
Live · Registered LIVE/REGISTRATION/Issued and Active
What this record means
The record shows that ATLANYS is a live, Principal Register registration owned by NOVARTIS AG, an Aktiengesellschaft organized in Switzerland, and it was officially registered on June 17 2025 after publication for opposition on April 29 2025. The registration covers Class 005 pharmaceuticals, specifically a long list of anti‑infectives, anti‑inflammatories, antibiotics, antivirals, cardiovascular, dermatological, inhaled respiratory, central‑nervous‑system, gastrointestinal, autoimmune, metabolic, endocrine, musculo‑skeletal and genitourinary pharmaceutical preparations, among others. Because the goods are narrowly confined to medicines, a similar name used for drugs or related health products would create the closest record‑based concern, while uses in unrelated fields would be farther from the scope shown here. The record does not give NOVARTIS control over every possible use of the word “ATLANYS.” The latest meaningful status event is the registration confirmation on June 17 2025; the prosecution history notes a notification of possible opposition processed on July 23 2026 but shows no actual opposition or cancellation. I’d treat this as a meaningful concern if you plan a pharma‑related brand with a similar name.
Informational only - not legal advice.Mark Trademark
| Drawing type | 4 - STANDARD CHARACTER MARK |
| Filing basis | Madrid Protocol (§66(a)). |
| Status | Registered. The registration date is used to determine when post-registration maintenance documents are due. |
Key dates
| Application filed | Nov 01, 2024 |
| Published for opposition | Apr 29, 2025 |
| Registered (Principal) | Jun 17, 2025 |
| Status date | Jun 17, 2025 |
Goods & services
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Madrid Protocol · §66(a)
| Intl. registration no. | 1266015 |
| Intl. registration date | Aug 10, 2015 |
| Intl. renewal date | Aug 10, 2035 |
| Date of automatic protection | Jun 19, 2026 |
| Notification of designation | Dec 19, 2024 |
| First refusal flag | No |
Owner & representation
| Owner | NOVARTIS AG |
| Address | CH-4002 Basel, SWITZERLAND |
| Entity | AKTIENGESELLSCHAFT (AG) - organized in SWITZERLAND |
| Attorney of record | Maury M. Tepper, III |
| Correspondent | Maury M. Tepper, III |
| Attorney email | m********@*****.com |
| Correspondent email | 2 emails |
| Correspondent phone | 9********3 |
| Correspondent address | Raleigh, NORTH |